title: [PSA-based screening for prostate cancer: a comparative analysis].
abstract: PSA-based screening has always been one of the controversial topics among urological researchers. In spite of its benefit in detecting early prostate cancer, PSA-based screening may not only result in widespread overdiagnosis and overtreatment of an often indolent disease, which is life-threatening in only a minority of patients, but also subject participators to such complications as erectile dysfunction and incontinence. Besides, whether PSA-based screening can reduce prostate cancer specific mortality has received considerable attention. This review offers a comparative analysis of recent studies on PSA-based screening for prostate cancer.
authors.affiliation: Department of Urology, Ruijin Hospital Affliated to Shanghai Jiaotong University, Shanghai 200025, China. caowanli@sjtu.edu.cn
authors.forename: Wan-Li
authors.initials: WL
authors.lastname: Cao
authors.forename: Fu-Kang
authors.initials: FK
authors.lastname: Sun
mesh_terms: D006801:Humans; D008297:Male; D017430:Prostate-Specific Antigen / Q000097:blood*; D011471:Prostatic Neoplasms / Q000097:blood / Q000175:diagnosis*
chemical_list: D017430:Prostate-Specific Antigen